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Abstract
Purpose: Objective of the study was to find out if there is any relation of number, size and type of gall stones and patient’s lipid
profile with the occurrence of gall bladder carcinoma (GBC) as presence of gall stones is considered to be the most important
risk factor for gall bladder cancer. Methods: 200 specimens of post-cholecystectomy gallbladder were studied. The number, size
and type of stones and lipid profile were compared in all these cases. Gross as well as histopathological examination of gall
bladders specimens was done. Results: 185 (92.5%) gall bladders were associated with gall stones. On histopathological exami-
nation, malignancy was found in 6 cases (3%) only and rest 194 cases (97%) revealed inflammatory/ non-neoplastic pathology.
A statistically significant difference was observed in the number of stones in gall bladders with malignancy than those with
benign lesions (P < 0.001). Similarly, a statistically significant difference was seen in terms of stone size between gallbladder
cancer (GBC) cases and those with benign pathology (P < 0.005). Benign lesions of gall bladders were mostly associated with
mixed type of stones whereas malignant cases were associated with pure cholesterol type of stones. No significant relation was
found between the patient’s lipid profile and occurrence of gallbladder carcinoma (GBC) (p > 0.005). Conclusion: Thus we con-
cluded that as the number, size and cholesterol gall stone increase the risk of gall bladder cancer also increases without any re-
lation with lipid profile.
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Introduction
Gallbladder cancer (GBC) was first described by Maximillian
Stoll in 1777 and even after 200 years, it is still considered to
be an extremely malignant disease with a poor prognosis.1, 2
Though this type of cancer is uncommon in US and Europe, it
is common in Chile, Peru, Japan and Korea.3 Comparison of
the data from the various population based cancer registries
in India indicates that GBC is common in Northern India.
Gallbladder carcinoma (GBC) has a preponderance for the
female sex and has been associated with many risk factors.4
Epidemiology studies demonstrate a close association be-
tween gallbladder carcinoma (GBC) and gall stones.5-11 Alt-
hough different associations have been described, gallstones
are found to be associated in 70% to 90% of the cases of
gallbladder cancer and approximately 0.4% of all patients
affected with gallstone disease eventually develop carcinoma
of the gallbladder.12 The incidence of gallbladder carcinoma
(GBC) parallels the prevalence of gallstone disease; large and
longstanding gallstones being associated with a higher risk of
gallbladder carcinoma (GBC).13 The risk of GBC is about four
to seven times in patients with gallstones.14,15
Gallstones injure the mucosal columnar epithelium of
gallbladder and thus result in various changes like metaplasia,
dysplasia and neoplasia in gall bladder epithelium.16 Higher
number of stones, as well as larger and heavier stones have
been associated with an increased risk for cancer causation.
Large and heavy gallbladder stones causes mechanical trauma
to mucosa and thus has been linked to the causation of dys-
plasia and progression to carcinoma.
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Cholesterol gall stones and mixed gall stones are commonly
associated with GBC and both share a number of risk factors,
including obesity, high fat diet and hyperlipidemia.17, 18 It is
still controversial whether serum cholesterol should be con-
sidered as a risk factor for gall stone diseases.19 To clarify this,
we examined the effect of serum lipids (total cholesterol,
triglycerides) and lipoproteins (HDL, LDL) on the risk of
gallbladder carcinoma (GBC).
This study was done to find out whether gall stones pose a
risk for gallbladder carcinoma (GBC) and if so, which pa-
rameter (number, size or type of stones) affects the most.
Lipid profile as a risk factor for gallbladder carcinoma (GBC)
was also assessed.
Methods and Materials
The present study comprised of 200 cholecystectomy speci-
mens received in the Department of Pathology of a govt.
medical college. The relevant information was gathered from
requisition slip accompanying the specimens. It included
complete history with the chief complaints, duration of ill-
ness, age, sex, occupation, dietary and bowel habits. The
specimens were studied macroscopically for evidence of any
gross abnormality. For microscopic examination, biopsy
sample were taken from different areas of gall bladder in-
cluding fundus, lateral walls, neck and from thickened area or
visible growth if any. Physical examination and biochemical
analysis of stones were done in all cases. Lipid profile was
estimated in all enrolled patients.
Physical characteristics of stones: Gall stones were assessed in
terms of
1) Number: Single/multiple.
2) Size: Averages of two major diameters were taken
with the help of verniercaliper. In the event of
multiple gall stones, diameter of the largest stone
was recorded.
3) Shape: Multifaceted/round/oval.
4) Color: Grayish white/yellow /brown black.
Biochemical Analysis of gall Stones
Biochemical analysis of gall stones was performed by the
method described by Oser.20 The gall stones were powdered
into fine particles and were analysed qualitatively. The gall
stones were analysed for the presence of cholesterol, bile
pigments, bile salts, calcium and phosphorous were catego-
rized as mixed/cholesterol/pigmented/combined.
Lipid Profile
After having written informed consent from all study sub-
jects, overnight fasting blood samples were collected. Within
3 hours of collection, samples were transported to the bio-
chemistry lab, government medical college where samples
were processed for the estimation of serum cholesterol, tri-
glycerides, HDL and LDL using the following assays.
(i) Total cholesterol: was analyzed by in vitro enzy-
matic colorimetric method described by Allain et
al.21
(ii) Triglycerides: was analyzed by in vitro enzymatic
colorimetric method described by McGowan et al.22
(iii) HDL-Cholesterol: was determined by enzymatic
method after precipitation of serum by phospho-
tungstate and magnesium chloride as described by
Burstein et al. 23
(iv) LDL-Cholesterol: was determined by the formula
devised by Friedewald et al. 24
GBC cases and gall bladders with benign pathology were
then compared with respect to the size, number and type of
stones and lipid profile.
Statistics
Statistical evaluation was performed with SPSS for Win-
dows® using Student’s t test and the Pearson correlation test.
P values less than 0.005 were regarded as statistically signifi-
cant. Results are reported as mean ± SD.
Results
This study consisted of 200 patients who underwent chole-
cystectomy. Predominantly the patients were females (176)
accounting for 88% whereas males were only 24 constituting
12%. Female to male ratio was 7.3:1. Majority of patients
(58%) were between 31 to 40 years of age.
FIG.1: Showing incidence of cholecystitis, cholesterolosis and ma-
lignancy of GB.
All specimens were subjected to microscopy and were cate-
gorized accordingly. Out of 200 cases, majority of the cases
(181) had cholecystitis (90.5%) and there were 13 cases
(6.5%) of cholesterolosis and 6 cases of malignancy account-
ing for 3% of the total cases (Table 1). All 6 cases (100%) of
GBC were females. Among them, 4 (66.67%) were in 5th and
7th decade. Out of 6 cases of malignancy, 4 (66.67%) had
diffusely growing type (Infiltrating type) of growth and rest
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2 cases (33.33%) had polypoidal (exophytic) growth pro-
truding within the lumen of the gall bladder. On microscop-
ic examination, all 6 cases were adenocarcinoma.
TABLE 1: Distribution of various lesions of gall bladder (n = 200).
Histopathological Diagnosis n % age
Cholecystitis
Acute cholecystitis 0 7 3.5
Chronic cholecystitis 162 81.0
Follicular cholecystitis 0 2 1.0
Eosinophiliccholecystitis 0 3 1.5
Xanthogranulomatous 0 4 2.0
Cholecystitisglandularis 0 3 1.5
Cholesterolosis 13 6.5
Malignancy 0 6 3.0
Total 200 100.0
Out of 200 cholecystectomy specimens, 185 gall bladders
were associated with gall stones (92.5%). GBC cases and gall
bladders with benign pathology were compared with respect
to the size, number and type of stone and serum lipid profile.
Following observations were recorded.
Number of stones
Out of 185 gall bladders with stones, 13 gall bladders (7%)
had single stone and 172 gall bladders (93%) were having
multiple stones.In multiple stones, the number ranged from
2 to 58. Only 1 case out of 185 cases (0.54%) had more than
50 stones.In 5 out of 6 malignant cases there were having
≥20 number of stones while only 20 out of 179 gall bladders
with benign pathology, had ≥ 20 number of stones. Number
of stones in patients with GBC was significantly higher than
those with benign lesions (P < 0.001) (Table 2). Thus there
appears to be a steady increase in the risk of gall bladder
cancer with increasing number of stones within the gall
bladder.
TABLE 2: Correlation of number, size and type of stones with gall
bladder pathology.
Stone Benign Pathology Malignancy p-value
Characteristics (n = 179) (n = 6)
Number <0.001
<20 159 1
≥20 20 5
Size <0.005
<3cm 172 4
≥3cm 7 2
Type <0.001
Mixed 166 2
Cholesterol 9 4
Pigmented 3 -
Combined 1 -
*This group is a subset of those cases which have gall stones (n = 185)
size of stones.
Size of stones
Out of 185 gall bladders with stones, 21 cases (11.35%) had
stone size less than 1 c, 109 (58.92%) had stone size between
1-1.9 cm, 45 (24.32%) had stone size between 2-2.9 cm and
rest 10 (5.41%) had stone size ≥ 3 cm. The maximum stone
size observed was 4.0 cm. In 4 out of 6 cases of malignancy,
the stone size was < 3 cm and in 2 cases it was ≥ 3cm. In 172
out of 179 gall bladders with benign pathology, stone size was
<3 cm. and in 7 cases, it was ≥ 3 cm. As p < 0.005, there is a
significant correlation between stone size and gall bladder
cancer (Table 2).
Type of stones
Out of 185 gall bladders with calculi, mixed stones were
present in 168 cases (90.8%), pure cholesterol stones in 13
cases (7.03%), pure pigmented stones in 3 cases (1.62%) and
combined stone in only 1 case. Grossly, in majority of the
cases, the mixed stones were multifaceted, grayish-white in
color. Their cut surface showed yellow colored radiating
crystals with a black centre. Cholesterol stones were mostly
solitary, round to oval and yellow in color, with a finely
granular and crystalline surface. On fracture, they showed
large flat crystals. Pigmented stones were brown black in
color and were mostly multifaceted. Combined gall stone
was found in a single gall bladder and was single and large in
size. Its cut surface showed central nucleus and outer shell.
Benign gall bladder lesions were mostly associated with
mixed type of stones while in majority (4 out of 6) of the
malignant cases, there were pure cholesterol type of stones.
As p < 0.001, there is highly significant risk of progression to
gall bladder cancer in patients with cholesterol gall stones
(Table 2). Thus, gall stones are one of the risk factors respon-
sible for progression to GBC and more so, in patients having
larger multiple cholesterol stones.
TABLE 3: Correlation between patients’ lipid profile and gall bladder
pathology (n = 200)
Pathology S.Chol HDL TG LDL
Mean +
S.D
Mean +
S.D
Mean +
S.D
Mean +
S.D
(range) (range) (range) (range)
(mg/dl) (mg/dl) (mg/dl) (mg/dl)
Benign 194.36 ±
36.3
51.04 ±
13.26
121.6 ±
47.86
138.08 ±
15.25
Lesion (145-320) (20-76) (30-210) (114-180)
Malignant 186 ±
54.21
47 ± 18.44 123 ±
59.21
146 ± 23.2
Lesion (101-270) (27-78) (49-200) (120-178)
t-value 0.38 0.53 0.006 0.83
p-value > 0.005 > 0.005 > 0.005 > 0.005
Significance Not
significant
Not
significant
Not
significant
Not
significant
Serum Cholesterol (S.Chol); High Density Lipoprotein (HDL); Tri-
glyceride (TG); Low density lipoprotein (LDL)
Lipid Profile
Mean values of fasting serum cholesterol, HDL, triglycerides
and LDL were almost similar in patients with benign lesions
and those with malignancy. As p > 0.005, there is no signifi-
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cant correlation between the patient's serum lipid profile and
GBC (Table 3).
Discussion
In Northern India, gallstones are seven times more common
with overall incidence of about 2.29%. This study was done
to find out relationship between size, number and type of
gall stones with the occurrence gall bladder cancer and also
to see its relation with lipid profile. This study comprised of
total 200 cholecystectomy cases out of which, 88% were
from female patients. It is a well-established fact that biliary
system of females is affected more frequently than those of
the males. According to a few authors, it is the disease of fair
sex only. Incidence of female preponderance in this study
comparable with other studies.16, 25-28 Why females suffer
more is unclear. Some authors have linked estrogen and sex
hormones with gall bladder disease presuming that estrogen
metabolism in the liver produces an irritant chemical which
causes inflammation and subsequently infection in the bili-
ary passages. This hypothesis is further supported because
majority of females are afflicted by the disease in their re-
productive period when estrogen levels are at the peak.
Higher and extended exposure to female sex hormones (such
as estrogen and progesterone) may be a main factor. There-
fore, early menarche, early first pregnancy, multiple preg-
nancies and delayed menopause may increase the risk of
gallbladder carcinoma.29
In the present study, chronic cholecystitis was the common-
est lesion found and malignancy was seen in only 6 cases
(3%). This may be because early development of symptoms
in cholecystitis cases and subsequent cholecystectomy would
not have allowed enough time for dysplasia to develop. Also
that carcinoma is more likely to be found in patients with
asymptomatic gall stones because they would have been
present in gall bladder over a longer period of time. A Indian
study recommends prophylactic cholecystectomy for
asymptomatic gallstones in young patients with thickened
gallbladder wall (greater than 3 mm); with large gallstones
(greater than 3 cm); and patients with porcelain gallbladder,
sessile polyps (greater than 1 cm), anomalous pancreaticobil-
iary junction, race and/or habitants of geographical locations
with high incidence rates of gallbladder cancer.30 Neverthe-
less, even though there are indications that performing
prophylactic cholecystectomies in patients with asympto-
matic gallstones may reduce the mortality rate of gallbladder
cancer, this subject is still controversial.
The relationship between gall stones and GBC has been well
established in literature. In our study, gall stones were found
in all 6 cases of malignancy and a significant association was
found between the number and size of stones with GBC. The
possible explanation behind this is that when gallbladder
gets with packed stones there may be interfere with the me-
chanical functioning of gall bladder which may be a prereq-
uisite step to eventual malignancy. The high risk of GBC
with large stones may be explained by a longer duration of
exposure to gall stones. This is also consistent with the view
that GBC is found mostly in older age group patients.
Gall stones cause mechanical damage on the mucosa of gall
bladder, this may be followed by compensatory tissue
growth, which may serve to enhance carcinogenesis. Thus
constant erosion of the gall bladder wall by gall stones over
prolonged time may constitute the risk for malignancy.
The almost complete occupation of the gall bladder lumen
by numerous and large gallstone could be a significant
marker for the increase in risk for GBC. The repeated me-
chanical irritation of gall bladder mucosa by these stones
may be responsible for the causation of GBC. This may well
explain the positive association between gall stone size 6, 31
and number 32-34 with GBC as observed in our study. But this
is in contradiction to the study by Moerman et al. 35 who did
not find any association between stone size and GBC.
We also observed that majority of the malignant cases had
pure cholesterol type of stones and none of these had either
brown or black pigment stones hence supporting the previ-
ous reports of association of GBC with cholesterol stones.33, 36,
37 Our findings are similar to a study from Japan by Kimura
et al. 38 which revealed that though most common type of
stones were of pigmented type, but in patients with GBC
cholesterol gall stones are most commonly found. Lorna and
Cooke 32 however, recorded association of mixed type of
stones with GBC. The possible association between choles-
terol stones and GBC cases could be changing life styles,
more westernized diet and increasing obesity. Rijvi and
Zuberi 39 also revealed that risk of developing GBC is associ-
ated with low calorie, high fat and low fiber intake. It is
proposed that they are linked at molecular level such that
there is simultaneous pumping of cholesterol (which precip-
itate as gall stones) and a food carcinogen into the bile in gall
bladder, the latter cause’s malignant transformation.
In the present study, no correlation was found between pa-
tients’ lipid profile and gall bladder pathology (Table -3). The
mean values of serum cholesterol, HDL, triglycerides and
LDL were almost similar in patients with benign lesions and
those with malignancy. The study by Aulakh et al.28 also did
not show any significant role of serum lipids in the causation
of gall bladder disease. Thus patients’ lipid profile may not
have an important role in the causation of gall bladder dis-
ease. Although our study did not prove any significant cor-
relation between serum lipids and GBC, there is need of fur-
ther studies in order to clarify the risk factors about
gallbladder cancer.
This small sample size study concluded that there is
correlation between presence of gallstones and in-
creased risk of carcinoma gallbladder but a larger sample
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size study is required to further strengthen these risk factors.
The understanding of various risk factors is essential to es-
tablish surgical treatments for the various pathological
gallbladder conditions, such as symptomatic or asymptomatic
calculouscholecystitis.
Conclusion
This small sample study has established the link between
gallstones and malignancy gallbladder. Nonetheless further
work is needed to understand various risk factors and to
establish surgical treatments for the various pathological
gallbladder conditions, such as symptomatic or asymptomatic
calculouscholecystitis.
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